Summary Summary Short summary of a recent publication, written by scientific experts.

Can the Boston Naming Test predict dysnomia in pharmacoresistant temporal lobe epilepsy?

Takeaway

  • Dysnomia severity in people with pharmacoresistant temporal lobe epilepsy following temporal lobe resections can be predicted using two easy-to-use, validated nomograms.

Why this matters

  • Validated nomograms can assist clinicians with identifying risk factors for post-operative naming decline, thus helping inform subsequent clinical decisions.